SCHEMBL564977

SCHEMBL564977

CC(C)CN(Cc1cc(Cl)c2c(c1)OCCCO2)C(=O)C(C)CNCc1cccc([N+](=O)[O-])c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.63
KMT2A Q03164 2/20 0.39
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
PTPN1 P18031 1/20 0.34
MEN1 O00255 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
TERT O14746 1/20 0.34
MLYCD O95822 1/20 0.34
NNMT P40261 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565571 0.92 PROKR2 (0.60) PROKR2KMT2AALDH1A1GAAMAPT
SCHEMBL564474 0.91 PROKR2 (0.62) PROKR2KMT2AALDH1A1GAAMAPT
SCHEMBL564752 0.89 PROKR2 (0.68) PROKR2KMT2AMEN1
SCHEMBL10107516 0.88 PROKR2 (0.68) PROKR2ALDH1A1
SCHEMBL10106938 0.88 PROKR2 (0.68) PROKR2ALDH1A1
SCHEMBL565594 0.88 PROKR2 (0.68) PROKR2KMT2AMEN1
SCHEMBL10107215 0.88 PROKR2 (0.68) PROKR2KMT2AALDH1A1MEN1
SCHEMBL565057 0.88 PROKR2 (0.56) PROKR2KMT2AALDH1A1GAAMAPT
SCHEMBL565524 0.88 PROKR2 (0.69) PROKR2KMT2ARECQLALDH1A1KDM4E
SCHEMBL565109 0.88 PROKR2 (0.69) PROKR2KMT2ARECQLALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885KMT2A 4644/4885OPRM1 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.